| The consensus molecular subtypes of colorectal cancer J Guinney, R Dienstmann, X Wang, A De Reynies, A Schlicker, ... Nature medicine 21 (11), 1350-1356, 2015 | 4097 | 2015 |
| Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments KA Baggerly, JS Morris, KR Coombes Bioinformatics 20 (5), 777-785, 2004 | 784 | 2004 |
| Body mass index and risk, age of onset, and survival in patients with pancreatic cancer D Li, JS Morris, J Liu, MM Hassan, RS Day, ML Bondy, JL Abbruzzese Jama 301 (24), 2553-2562, 2009 | 528 | 2009 |
| Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with … S Kopetz, PM Hoff, JS Morris, RA Wolff, C Eng, KY Glover, R Adinin, ... Journal of clinical oncology 28 (3), 453, 2010 | 527 | 2010 |
| Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma JA Ajani, PF Mansfield, N Janjan, J Morris, PW Pisters, PM Lynch, B Feig, ... Journal of clinical oncology 22 (14), 2774-2780, 2004 | 498 | 2004 |
| Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation LR Chirieac, SG Swisher, JA Ajani, RR Komaki, AM Correa, JS Morris, ... Cancer 103 (7), 1347-1355, 2005 | 486 | 2005 |
| Wavelet-based functional mixed models JS Morris, RJ Carroll Journal of the Royal Statistical Society Series B: Statistical Methodology …, 2006 | 459 | 2006 |
| Functional regression JS Morris Annual Review of Statistics and Its Application 2, 321-359, 2015 | 450 | 2015 |
| Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients TM Pawlik, F Izzo, DS Cohen, JS Morris, SA Curley Annals of surgical oncology 10, 1059-1069, 2003 | 425 | 2003 |
| Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum JS Morris, KR Coombes, J Koomen, KA Baggerly, R Kobayashi Bioinformatics 21 (9), 1764-1775, 2005 | 420 | 2005 |
| Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma MB Thomas, R Chadha, K Glover, X Wang, J Morris, T Brown, A Rashid, ... Cancer 110 (5), 1059-1067, 2007 | 410 | 2007 |
| Improved peak detection and quantification of mass spectrometry data acquired from surface‐enhanced laser desorption and ionization by denoising spectra with the undecimated … KR Coombes, S Tsavachidis, JS Morris, KA Baggerly, MC Hung, ... Proteomics 5 (16), 4107-4117, 2005 | 408 | 2005 |
| Cutaneous angiosarcoma of the scalp: a multidisciplinary approach TM Pawlik, AF Paulino, CJ Mcginn, LH Baker, DS Cohen, JS Morris, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2003 | 402 | 2003 |
| Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma MB Thomas, JS Morris, R Chadha, M Iwasaki, H Kaur, E Lin, A Kaseb, ... J Clin Oncol 27 (6), 843-850, 2009 | 387 | 2009 |
| Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer KA Baggerly, JS Morris, SR Edmonson, KR Coombes Journal of the National Cancer Institute 97 (4), 307-309, 2005 | 369 | 2005 |
| Differential expression in SAGE: accounting for normal between-library variation KA Baggerly, L Deng, JS Morris, CM Aldaz Bioinformatics 19 (12), 1477-1483, 2003 | 367 | 2003 |
| Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome JA Ajani, PF Mansfield, CH Crane, TT Wu, S Lunagomez, PM Lynch, ... Journal of clinical oncology 23 (6), 1237-1244, 2005 | 344 | 2005 |
| The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells I Shureiqi, W Jiang, X Zuo, Y Wu, JB Stimmel, LM Leesnitzer, JS Morris, ... Proceedings of the National Academy of Sciences 100 (17), 9968-9973, 2003 | 287 | 2003 |
| Classifying colorectal cancer by tumor location rather than sidedness highlights a continuum in mutation profiles and consensus molecular subtypes JM Loree, AAL Pereira, M Lam, AN Willauer, K Raghav, A Dasari, ... Clinical Cancer Research 24 (5), 1062-1072, 2018 | 284 | 2018 |
| Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization KR Coombes, HA Fritsche Jr, C Clarke, JN Chen, KA Baggerly, JS Morris, ... Clinical chemistry 49 (10), 1615-1623, 2003 | 283 | 2003 |
Scott KopetzUniversity of Texas MD Anderson Cancer CenterVerified email at mdanderson.org
